Nothing Special   »   [go: up one dir, main page]

CU20190030A7 - Composiciones de vacunas antineumocócicas polivalentes que comprenden conjugados de polisacárido-proteína - Google Patents

Composiciones de vacunas antineumocócicas polivalentes que comprenden conjugados de polisacárido-proteína

Info

Publication number
CU20190030A7
CU20190030A7 CU2019000030A CU20190030A CU20190030A7 CU 20190030 A7 CU20190030 A7 CU 20190030A7 CU 2019000030 A CU2019000030 A CU 2019000030A CU 20190030 A CU20190030 A CU 20190030A CU 20190030 A7 CU20190030 A7 CU 20190030A7
Authority
CU
Cuba
Prior art keywords
polyvalent
pneumococcal
antineumococcal
compositions
vaccine compositions
Prior art date
Application number
CU2019000030A
Other languages
English (en)
Other versions
CU24660B1 (es
Inventor
Rajendar Burki
Deviprasanna Chakka
Mahima Datla
Sreenivasa Rao Ganti
Narender Dev Mantena
Ramesh Venkat Matur
Rajan Sriraman
Satyam Naidu Sureddi
Original Assignee
Biological E Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biological E Ltd filed Critical Biological E Ltd
Publication of CU20190030A7 publication Critical patent/CU20190030A7/es
Publication of CU24660B1 publication Critical patent/CU24660B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>La presente divulgación se refiere a composiciones de vacunas antineumocócicas polivalentes que comprenden serotipos de polisacáridos neumocócicos capsulares, cada uno conjugado individualmente con proteínas portadoras. AI conjugarse, Ia combinación del serotipo de polisacárido capsular neumocócico y Ia proteína portadora se denomina en Ia presente un conjugado de polisacárido-proteína. Las composiciones de vacunas antineumocócicas pueden comprender además uno o más de los siguientes: un portador aceptable desde el punto de vista farmacéutico, un diluyente aceptable desde el punto de vista farmacéutico, un amortiguador, un conservante, un estabilizante, un adyuvante y/o un excipiente de liofilización. También se proporcionan métodos para preparar y administrar las composiciones de vacunas antineumocócicas descritas en Ia presente.</p>
CU2019000030A 2016-09-30 2017-09-29 Composiciones de vacunas multivalentes que comprenden conjugados de polisacárido-proteína de streptococcus pneumoniae utilizando proteínas portadoras psaa y crm197 CU24660B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201641033563 2016-09-30
PCT/US2017/054237 WO2018064444A1 (en) 2016-09-30 2017-09-29 Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates

Publications (2)

Publication Number Publication Date
CU20190030A7 true CU20190030A7 (es) 2019-11-04
CU24660B1 CU24660B1 (es) 2023-05-11

Family

ID=60117775

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2019000030A CU24660B1 (es) 2016-09-30 2017-09-29 Composiciones de vacunas multivalentes que comprenden conjugados de polisacárido-proteína de streptococcus pneumoniae utilizando proteínas portadoras psaa y crm197

Country Status (20)

Country Link
US (1) US11547752B2 (es)
EP (1) EP3518965A1 (es)
JP (2) JP2019529497A (es)
KR (1) KR102608081B1 (es)
CN (1) CN109789198B (es)
AU (1) AU2017336806B2 (es)
BR (1) BR112019006278A2 (es)
CA (1) CA3037056A1 (es)
CL (1) CL2019000849A1 (es)
CO (1) CO2019002955A2 (es)
CU (1) CU24660B1 (es)
EA (1) EA201990838A1 (es)
IL (2) IL265623B2 (es)
MX (1) MX2019003593A (es)
NZ (1) NZ752348A (es)
PH (1) PH12019500672A1 (es)
SA (1) SA519401317B1 (es)
UA (1) UA126385C2 (es)
WO (1) WO2018064444A1 (es)
ZA (1) ZA201901170B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL255106B2 (en) 2015-05-04 2023-04-01 Pfizer Protein-polysaccharide conjugates of group b streptococcus, methods for preparing conjugates, immunogenic preparations containing conjugates and their uses
JP7164200B2 (ja) * 2016-03-31 2022-11-01 ポゴナ， エルエルシー サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法
MX2019007910A (es) 2016-12-30 2019-12-05 Sutrovax Inc Conjugados de polipeptido-antigeno con aminoacidos no naturales.
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
GB201711635D0 (en) * 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition
AU2018400751B2 (en) 2017-12-06 2022-07-21 Merck Sharp & Dohme Llc Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
KR102486891B1 (ko) * 2018-02-05 2023-01-10 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
IL276229B2 (en) * 2018-02-05 2024-01-01 Sanofi Pasteur Inc A multivalent pneumococcal protein-polysaccharide conjugate preparation
KR20190121713A (ko) 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
WO2020010000A1 (en) * 2018-07-04 2020-01-09 Sutrovax, Inc. Improved methods for the preparation of immunogenic conjugates
EP3817775B1 (en) * 2018-07-04 2024-09-04 Vaxcyte, Inc. Improvements in immunogenic conjugates
JP7337145B2 (ja) * 2018-07-21 2023-09-01 バイオロジカル イー リミテッド 保存剤系を含むワクチン製剤
AU2019341723B2 (en) * 2018-09-23 2024-03-21 Biological E Limited Purified capsular polysaccharides of Streptococcus pneumoniae
EP3863667A4 (en) * 2018-10-12 2022-08-17 Biological E Limited POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE VACCINE
AU2019401535B2 (en) * 2018-12-19 2023-12-14 Merck Sharp & Dohme Llc Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2020152706A1 (en) * 2019-01-21 2020-07-30 Biological E Limited Multivalent pneumococcal conjugate vaccine compositions
WO2020157772A1 (en) * 2019-01-28 2020-08-06 Biological E Limited Multivalent pneumococcal polysaccharide-protein conjugate vaccine compositions
CN109771640A (zh) * 2019-02-28 2019-05-21 北京智飞绿竹生物制药有限公司 多价肺炎球菌结合疫苗
EP3980055A4 (en) * 2019-06-05 2023-07-26 Merck Sharp & Dohme LLC IMMUNOGENIC PNEUMOCOCCUS POLYSACCHARID-PROTEIN CONJUGATE OF SEROTYPE 35B AND CONJUGATION METHODS FOR ITS PRODUCTION
AU2020289048A1 (en) * 2019-06-05 2021-12-09 Merck Sharp & Dohme Llc Methods of treating patients with an immunogenic composition that protects against
CN110302375A (zh) * 2019-06-27 2019-10-08 康希诺生物股份公司 一种糖缀合物及其用途
TW202116352A (zh) * 2019-07-18 2021-05-01 南韓商賽特瑞恩股份有限公司 包含多價肺炎球菌多醣-蛋白共軛物的免疫組成物、醫藥組成物及其用途
CN114728050A (zh) * 2019-07-31 2022-07-08 圣诺菲·帕斯图尔公司 多价肺炎球菌多糖-蛋白质缀合物组合物及其使用方法
CN110804097B (zh) * 2019-10-30 2021-02-26 云南沃森生物技术股份有限公司 一种同时制备两种单克隆抗体的方法
US20210220461A1 (en) * 2020-01-17 2021-07-22 Inventprise, Llc Multivalent Streptococcus Vaccines
US12053515B2 (en) 2020-08-10 2024-08-06 Inventprise, Inc. Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
KR20220102871A (ko) * 2021-01-14 2022-07-21 (주)셀트리온 다가 폐렴구균 다당류-단백질 접합체를 포함하는 면역원성 조성물
EP4297776A1 (en) * 2021-02-26 2024-01-03 Biological E Limited Activated-quenched polysaccharide and improved methods for quantification of polysaccharide in a vaccine composition
US20240181028A1 (en) * 2022-11-22 2024-06-06 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027888B1 (en) 1979-09-21 1986-04-16 Hitachi, Ltd. Semiconductor switch
US5360897A (en) 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
NZ249704A (en) 1992-02-11 1996-11-26 Jackson H M Found Military Med A two carrier immunogenic construct comprising a 70+ kd molecule conjugated to at least 1 t-dependent antigen, preparation, compositions containing the construct
DE69434079T2 (de) 1993-03-05 2005-02-24 Wyeth Holdings Corp. Plasmid zur Herstellung von CRM-Protein und Diphtherie-Toxin
ATE254475T1 (de) 1993-09-22 2003-12-15 Jackson H M Found Military Med Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
NZ304715A (en) 1995-03-22 1999-07-29 Jackson H M Found Military Med Production of immunogenic constructs using organic cyanylating reagents to activate carbohydrates and then coupling the carbohydrate to a protein, peptide or hapten
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
FR2763244B1 (fr) * 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc Composition vaccinale multivalente a porteur mixte
US8048432B2 (en) 2003-08-06 2011-11-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Polysaccharide-protein conjugate vaccines
EP2425856A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
LT2384765T (lt) * 2005-12-22 2017-01-10 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae vakcina
KR20130135399A (ko) 2006-03-17 2013-12-10 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 복합 다가 면역원성 콘쥬게이트의 제조 방법
US20070253985A1 (en) * 2006-04-26 2007-11-01 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
EA020817B1 (ru) 2007-06-26 2015-02-27 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
US8003112B2 (en) * 2009-04-16 2011-08-23 Howard University Meningococcal and pneumococcal conjugate vaccine and method of using same
CN101590224A (zh) 2009-06-30 2009-12-02 广州精达医学科技有限公司 高效14价肺炎球菌结合疫苗
TW201136603A (en) 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
WO2011151841A1 (en) * 2010-05-31 2011-12-08 Panacea Biotec Limited Fermentation process for streptococcus pneumoniae
KR102057217B1 (ko) 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103623401A (zh) 2012-08-23 2014-03-12 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
CN103656632B (zh) 2012-09-24 2016-01-13 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖组合物、其制备方法及应用
CN103656631B (zh) 2012-09-24 2015-08-19 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法
KR20140075201A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
KR20140075196A (ko) 2012-12-11 2014-06-19 에스케이케미칼주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN104069488A (zh) 2013-03-29 2014-10-01 北京科兴中维生物技术有限公司 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法
WO2016079755A1 (en) 2014-11-20 2016-05-26 Biological E Limited Codon optimized polynucleotide for high level expression of crm197
CN107835821B (zh) 2015-04-28 2022-01-28 生物E有限公司 用于从微生物荚膜多糖分离蛋白质和其他杂质的方法
RS61440B1 (sr) * 2015-06-23 2021-03-31 Biological E Ltd Multivalentna pneumokokna konjugatna vakcina
EP3296741B1 (en) * 2016-09-14 2019-08-21 Serum Institute of India Private Limited Multiplex bead based assay for quantification of multiple types of carrier protein in a multivalent conjugate vaccine composition

Also Published As

Publication number Publication date
CL2019000849A1 (es) 2019-09-23
IL265623A (en) 2019-05-30
IL265623B2 (en) 2023-04-01
SA519401317B1 (ar) 2023-11-14
EA201990838A1 (ru) 2019-08-30
BR112019006278A2 (pt) 2019-07-02
AU2017336806A1 (en) 2019-05-02
IL297575B1 (en) 2023-08-01
CU24660B1 (es) 2023-05-11
WO2018064444A1 (en) 2018-04-05
UA126385C2 (uk) 2022-09-28
PH12019500672A1 (en) 2019-07-29
JP2022105155A (ja) 2022-07-12
CA3037056A1 (en) 2018-04-05
ZA201901170B (en) 2024-08-28
IL265623B (en) 2022-12-01
MX2019003593A (es) 2019-06-10
US20190224295A1 (en) 2019-07-25
JP2019529497A (ja) 2019-10-17
CN109789198B (zh) 2024-08-16
KR102608081B1 (ko) 2023-11-29
AU2017336806B2 (en) 2024-06-27
NZ752348A (en) 2022-11-25
JP7403576B2 (ja) 2023-12-22
AU2017336806A8 (en) 2019-05-16
CO2019002955A2 (es) 2019-06-11
IL297575B2 (en) 2023-12-01
CN109789198A (zh) 2019-05-21
KR20190066032A (ko) 2019-06-12
IL297575A (en) 2022-12-01
US11547752B2 (en) 2023-01-10
EP3518965A1 (en) 2019-08-07

Similar Documents

Publication Publication Date Title
CU20190030A7 (es) Composiciones de vacunas antineumocócicas polivalentes que comprenden conjugados de polisacárido-proteína
BR112020004396A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
BR112020004502A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
BR112020004509A8 (pt) Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado
ECSP20032085A (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y métodos de uso de estos
CO2017011245A2 (es) Conjugados proteína-polisacárido de estreptococo grupo b, métodos para producir conjugados, composiciones inmunógenas que comprenden conjugados y sus usos
BR112020004471A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
BR112018007812A2 (pt) polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica.
PE20211888A1 (es) Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso
CO7240387A2 (es) Composición conjugada de polisacáridos-proteínas neumocócica polivalente
CO7461130A2 (es) Composición multivalente de conjugados de proteína-polisacárido neumococico
AR092897A1 (es) Composiciones inmunogenicas
BR112016015422A2 (pt) formulações de vacina de frasco único
CO2021007863A2 (es) Vacuna conjugada polisacárido-proteína neumocócica multivalente
AR088907A1 (es) Vacuna
BR112019004303A2 (pt) composição de conjugados multivalentes de polissacarídeo capsular pneumocócico-proteína portadora e uso da mesma
AR095425A1 (es) Vacuna, uso y procedimiento para prevenir una infección por picornavirus
AR104514A1 (es) Conjugados proteína-polisacárido de estreptococo grupo b, métodos para producir conjugados, composiciones inmunógenas que comprenden conjugados y sus usos